4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001193125-26-276236
President & CEO sold 20,000 shares at an average $60.75 ($1,215,056)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-16 | Sale : show line 1 in the form 10b5-1 | −5,303 | $59.97 | $318,021 | 69,742 | D |
| 2026-06-16 | Sale : show line 2 in the form 10b5-1 | −4,697 | $60.71 | $285,155 | 65,045 | D |
| 2026-06-17 | Sale : show line 3 in the form 10b5-1 | −5,500 | $60.81 | $334,455 | 59,545 | D |
| 2026-06-17 | Sale : show line 4 in the form 10b5-1 | −4,500 | $61.65 | $277,425 | 55,045 | D |
| Open-market sales · 20,000 sh · avg $60.75 · $1,215,056 | ||||||
Loading xslF345X06/ownership.xml…